Using in vivo models of acute myeloid leukemia, it has been shown that miR-155 can also promote FLT3-ITD-induced myeloproliferative in the bone marrow, spleen, and blood by suppressing the interferon response (Wallace et al., 2017[52]). This evidence concerns the gene FLT3 and acute myeloid leukemia.